Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Erythema
ADR ID BADD_A01535
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.06      Erythemas
23.03.06.001      Erythema
Description Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes. [MeSH]
MedDRA Code 10015150
MeSH ID D004890
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Erythema | Erythema auricular | Erythema circumocular-blepharal | Erythema diffuse | Erythema facial | Erythema NOS | Erythema oedematous | Erythematous conditions | Face red | Localized erythema | Lower legs erythematous | Other specified erythematous condition | Other specified erythematous conditions | Red face | Red neck | Redness | Redness facial | Redness generalised | Redness generalized | Redness of external ear | Redness of face | Redness of legs | Redness of nares | Skin erythema | Skin hyperaemia | Skin hyperemia | Skin red | Unspecified erythematous condition | Erythema periorbital | Redness in breast | Generalised erythema | Erythema ear | Erythema edematous | Infiltrative erythema | Generalized erythema | Localised erythema | Periungual erythema | Scalp redness | Erythema of extremities | Red hands | Erythemas
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02364Vinorelbine tartrate--
BADD_D02367Voltaren--
BADD_D02369Voriconazole0.114428%
BADD_D02375Water0.073298%
BADD_D02380Zanamivir0.000706%
BADD_D02383Zidovudine--
BADD_D02389Ziprasidone hydrochloride--
BADD_D02392Zoledronic acid0.053250%
BADD_D02393Zolmitriptan0.000677%
BADD_D02394Zolpidem--
BADD_D02398Zuclopenthixol--
BADD_D02404Latanoprostene bunod0.000365%
BADD_D02412Octreotide0.001565%
BADD_D02415Ziprasidone--
BADD_D02428Loperamide--
BADD_D02432Glycopyrronium0.006052%
BADD_D02442Magnesium oxide0.000274%
BADD_D02446Prasterone0.014812%
BADD_D02450Crisaborole0.027663%
BADD_D02463Pitavastatin0.000618%
BADD_D02471Oxygen0.003965%
BADD_D02473Sodium chloride0.003524%
BADD_D02480Alectinib--
BADD_D02483Ribociclib0.001959%
BADD_D02489Neratinib0.001119%
BADD_D02492Deflazacort0.002232%
BADD_D02495Duvelisib0.000246%
BADD_D02515Pexidartinib0.000627%
BADD_D02519Netarsudil0.000365%
BADD_D02537Cabotegravir0.000423%
The 28th Page    First    Pre   28 29 30    Next   Last    Total 30 Pages